ScionxBio

Business Services · 11-50 Employees

View Company Info for Free

Overview

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About ScionxBio

ScionxBio is a preclinical biotechnology company developing long-acting programmable xRNA therapeutics for chronic cardiometabolic diseases. The company leverages its proprietary TERÅ® platform, which combines synthetic chemistry and deep learning to engineer RNA molecules with enhanced stability and sustained protein expression. By extending the duration of therapeutic protein production from a single administration, ScionxBio aims to reduce dosing frequency and improve treatment outcomes for patients with chronic diseases. The company emerged as an independent spinout from Eleven Therapeutics to focus exclusively on advancing next-generation RNA medicines.Explore more
ScionxBio's Social MediaPopular SearchesScionxBioSIC Code 87,873NAICS Code 54,541Show more

ScionxBio Org Chart

AG

Chief Executive Officer

PhoneEmail

Is ScionxBio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Top Business Services Companies

Frequently Asked Questions Regarding ScionxBio

What is ScionxBio's official website?
ScionxBio's official website is www.scionxbio.com
What is ScionxBio's Revenue?
ScionxBio's revenue is <$5 Million
What is ScionxBio's SIC code?
ScionxBio's SIC: 87,873
What is ScionxBio's NAICS code?
ScionxBio's NAICS: 54,541
How many employees does ScionxBio have?
ScionxBio has 11-50 employees
What industry does ScionxBio belong to?
ScionxBio is in the industry of: Business Services, Research & Development
What does ScionxBio do?

ScionxBio is a preclinical biotechnology company developing long-acting programmable xRNA therapeutics for chronic cardiometabolic diseases. The company leverages its proprietary TERÅ® platform, which combines synthetic chemistry and deep learning to engineer RNA molecules with enhanced stability and sustained protein expression. By extending the d... uration of therapeutic protein production from a single administration, ScionxBio aims to reduce dosing frequency and improve treatment outcomes for patients with chronic diseases. The company emerged as an independent spinout from Eleven Therapeutics to focus exclusively on advancing next-generation RNA medicines.Read More

What are ScionxBio social media links?
ScionxBio Linkedin page
Is ScionxBio a public company?
ScionxBio is private company therefore does not currently have an official ticker symbol
See more information about ScionxBio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.